Collagen sponge in gynecologic use
- PMID: 7024877
Collagen sponge in gynecologic use
Abstract
PIP: This study summarizes present knowledge on the use of the collagen sponge (CS) in gynecology. All the properties of collagen are preserved when it is reconstructed into the 3-dimensional matrix of the sponge; fluid binding capacity is much higher than with polyurethane or cellulose sponges, and there is no cytotoxicity when it comes into contact with an epithelial surface; moreover, collagen appears to be a natural substrate for cell attachment, and it is biodegradable. Contraceptive CSs with a diameter of 6-8 cm, a string for removal, and an applicator for insertion have been tested. Contraceptive CSs have a pH 4.5 adjusted with 0.2 M citrate buffer; they produce an extrememly good mechanical barrier in the upper third of the vagina and can be left in place up to 48 hours following coitus without malodor formation. From a total of 41 postcoital tests performed with CS alone in 28 women, 22% showed the presence of 1 or more motile spermatozoa. In 33 postcoital tests performed with the combination of CS and spermicidal cream, there were only 6% positive tests. The use of spermicidal cream alone showed a 14% failure rate. These results certainly favor the combination of a mechanical and a chemical barrier. Zinc medicated CSs (ZnCSs) were tested in 10 patients with primary genital herpes; the patients were treated for 2-3 weeks and were observed for recurrent disease for a total of 6 months. All patients were treated with a ZnCS in the shape of a 2.5 by 10 cm cyclinder containing 40 mg ZnSO4; 30% of patients had a recurrence of the disease within 6 months. It is very possible that a hygienic tampon made of CS may overcome the drawbacks of commercially available hygienic tampons; weight is much lower, while water uptake and water binding capacity are much greater.
Similar articles
-
Preliminary testing of the contraceptive collagen sponge.Obstet Gynecol. 1980 Oct;56(4):503-6. Obstet Gynecol. 1980. PMID: 7191547
-
The vaginal contraceptive sponge.IPPF Med Bull. 1984 Jun;18(3):1-2. IPPF Med Bull. 1984. PMID: 12266284
-
Vaginal contraception--an update.Contracept Deliv Syst. 1982 Apr;3(2):75-81. Contracept Deliv Syst. 1982. PMID: 12338173
-
Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.Am J Obstet Gynecol. 1985 Feb 1;151(3):325-9. doi: 10.1016/0002-9378(85)90296-0. Am J Obstet Gynecol. 1985. PMID: 2982268
-
Comparative contraceptive efficacy of the female condom and other barrier methods.Fam Plann Perspect. 1994 Mar-Apr;26(2):66-72. Fam Plann Perspect. 1994. PMID: 8033980 Review.
Cited by
-
Growth and Osteogenic Differentiation of Discarded Gingiva-Derived Mesenchymal Stem Cells on a Commercial Scaffold.Front Cell Dev Biol. 2020 May 21;8:292. doi: 10.3389/fcell.2020.00292. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32509773 Free PMC article.
-
The development of collagen based composite scaffolds for bone regeneration.Bioact Mater. 2017 Sep 18;3(1):129-138. doi: 10.1016/j.bioactmat.2017.08.004. eCollection 2018 Mar. Bioact Mater. 2017. PMID: 29744450 Free PMC article. Review.
-
Improving the cell distribution in collagen-coated poly-caprolactone knittings.Tissue Eng Part C Methods. 2012 Oct;18(10):731-9. doi: 10.1089/ten.TEC.2011.0593. Epub 2012 May 10. Tissue Eng Part C Methods. 2012. PMID: 22480276 Free PMC article.
-
Zinc salts inactivate clinical isolates of herpes simplex virus in vitro.J Clin Microbiol. 2000 May;38(5):1758-62. doi: 10.1128/JCM.38.5.1758-1762.2000. J Clin Microbiol. 2000. PMID: 10790094 Free PMC article.